NCT03800901 (Q-IQ) is a NA clinical trial of Continuing Medical Education in Diabetes, sponsored by Qure Healthcare, LLC.

Who is sponsoring NCT03800901?

NCT03800901 is sponsored by Qure Healthcare, LLC.

What drugs are being tested in NCT03800901?

Interventions in NCT03800901: Continuing Medical Education, Quality IQ Patient Simulations.

What condition does NCT03800901 study?

NCT03800901 studies Diabetes, Hypertension, Depression, Osteoarthritis, Asthma, Pain, Heart Failure.

Is NCT03800901 still recruiting?

NCT03800901 is currently completed. Last updated 3 March 2020.

Last reviewed 2020-03-03 · How we verify

NCT03800901: Q-IQ

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quality IQ Patient Simulation Physician Practice Measurement and Engagement

Completed NA Last updated 3 March 2020

What this trial tests

NA trial testing Continuing Medical Education in Diabetes in 187 participants. Completed in 15 April 2019.

Timeline

11 January 2019

Primary endpoint
11 March 2019

15 April 2019

Quick facts

Lead sponsor	Qure Healthcare, LLC
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	187
Start date	11 January 2019
Primary completion	11 March 2019
Estimated completion	15 April 2019
Sites	1 location across United States

Drugs / interventions tested

Continuing Medical Education
Quality IQ Patient Simulations

Conditions studied

Diabetes — all drugs for Diabetes →
Hypertension — all drugs for Hypertension →
Depression — all drugs for Depression →
Osteoarthritis — all drugs for Osteoarthritis →

Sponsor

Qure Healthcare, LLC — full company profile →

Who can join

Eligibility, any sex, with Diabetes or Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will test the quality of physician care decisions using a patient-simulation based measurement and feedback approach that combines multiple-choice care decisions with real-time, personalized scoring and feedback. The study will also measure the impact of gaming-inspired competition and motivation, including a weekly leaderboard, to improve evidence-based care decisions. In addition, the study the test the impact of CME and MOC credits on participant engagement in the process.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Measuring and Improving Evidence-Based Patient Care Using a Web-Based Gamified Approach in Primary Care (QualityIQ): Randomized Controlled Trial.
Burgon T, Casebeer L, Aasen H, Valdenor C, et al · · 2021 · cited 13× · PMID 34941547 · DOI 10.2196/31042

Verify or expand the search:

Other recruiting trials for Diabetes

Currently open trials in the same condition.

NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
NCT07417865 — ECHO Diabetes FQHC · recruiting

Other Qure Healthcare, LLC trials

Trials by the same sponsor.

NCT07099001 — Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay · NA · completed
NCT05702385 — Clinical Utility Study for Exo-PDAC · NA · withdrawn
NCT05603299 — Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' Dawn Test · NA · withdrawn
NCT05910697 — Clinical Utility of MyProstateScore 2.0 P2 · NA · terminated
NCT05525806 — Clinical Utility Study for MyProstateScore+ · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03800901 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Qure Healthcare, LLC
Last refreshed: 3 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03800901.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing